No Data
No Data
Announcement of expected loss in performance for the first half of 2024.
Beihai Gofar Chuanshan Biological (600538.SH): expects a pre-loss of about 16 million yuan in the first half of the year.
On July 9th, Gofar Chuanshan Biological (600538.SH) announced its performance forecast for the first half of 2024, expecting a net income attributable to the mother company's owner of about -16 million yuan. This represents an increase in losses compared to the same period last year. The net income attributable to the mother company's owner after deducting non-recurring gains and losses is expected to be about -17 million yuan for the first half of 2024.
China Development Co., Ltd. (600538.SH): Vigorously expand the field of general health and judicial IVD
Gelonghui, May 15, 丨 Guofa Co., Ltd. (600538.SH) said at the performance briefing that the stock price is affected by multiple factors such as macroeconomics, industry policies, and market environment. The company's management closely monitors the company's stock price fluctuations and attaches great importance to market value management. The company will focus on its main business, continue to do a good job in business management, consolidate the foundation for development, and continuously enhance the company's internal value. At the same time, we will continue to focus on the company's long-term development goals, innovative ideas, and focus on health development strategies, take high-tech development as the lead, use existing industries as the foundation, biotechnology as the core, and vigorously expand the field of health and judicial IVD, especially the roots
China Fa Co., Ltd. (600538.SH) announced first-quarter results with a net loss of 12.358 million yuan
Guofa Co., Ltd. (600538.SH) released its report for the first quarter of 2024, achieving operating income of 875 during the reporting period...
China Fa Co., Ltd. (600538.SH) announced 2023 annual results with a net loss of 82.3083 million yuan, which changed year-on-year from profit to loss
Guofa Co., Ltd. (600538.SH) disclosed its 2023 annual report. The company achieved operating income of 3 during the reporting period...
There's Reason For Concern Over Beihai Gofar Chuanshan Biological Co., Ltd.'s (SHSE:600538) Massive 26% Price Jump
Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) shares have had a really impressive month, gaining 26% after a shaky period beforehand. Notwithstanding the latest gain, the annual share p
No Data